A standardized clinical evaluation of phenotypic diversity in diabetic polyneuropathy.
Diabetic polyneuropathy (DPN) is a major cause of neuropathic pain and a frequent target condition in analgesic treatment trials. Differences in the clinical symptoms and signs associated with DPN suggest distinct pathophysiological mechanisms underlying nerve damage and dysfunction that are likely...
Main Authors: | Scholz, J, Rathmell, J, David, W, Chad, D, Broderick, A, Perros, S, Shin, N, Wells, J, Davis, J, DiMaggio, C, Wang, S, Tate, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Lippincott, Williams & Wilkins
2016
|
Similar Items
-
Update on the management of diabetic polyneuropathies
by: Shakher J, et al.
Published: (2011-07-01) -
Diabetic polyneuropathy: efficacy of Actovegin
by: I. A. Strokov, et al.
Published: (2013-12-01) -
Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
by: S. S. Nikitin, et al.
Published: (2021-12-01) -
Organophosphate and Delayed Polyneuropathy
by: J Gordon Millichap
Published: (1993-04-01) -
Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes
by: Sasha Smith, et al.
Published: (2022-07-01)